Click for best price
Prostate Cancer Biomarker Market Size, Share 2022
Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system.
This report contains market size and forecasts of Prostate Cancer Biomarker in Global, including the following market information:
Global Prostate Cancer Biomarker Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Prostate Cancer Biomarker market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Urine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Prostate Cancer Biomarker include Thermo Fisher Scientific, QIAGEN, Roche Diagnostics, Beckman Coulter, Myriad Genetics, Sanofi-Aventis, Pfizer and MDx Health, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Prostate Cancer Biomarker companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prostate Cancer Biomarker Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Prostate Cancer Biomarker Market Segment Percentages, by Type, 2021 (%)
Urine
Blood
Serum
Global Prostate Cancer Biomarker Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Prostate Cancer Biomarker Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Cancer Institutes
Global Prostate Cancer Biomarker Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Prostate Cancer Biomarker Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prostate Cancer Biomarker revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Prostate Cancer Biomarker revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific
QIAGEN
Roche Diagnostics
Beckman Coulter
Myriad Genetics
Sanofi-Aventis
Pfizer
MDx Health
| Report Attributes |
Report Details |
| Report Title |
Prostate Cancer Biomarker Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
66 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Prostate Cancer Biomarker Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prostate Cancer Biomarker Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prostate Cancer Biomarker Overall Market Size
2.1 Global Prostate Cancer Biomarker Market Size: 2021 VS 2028
2.2 Global Prostate Cancer Biomarker Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Prostate Cancer Biomarker Players in Global Market
3.2 Top Global Prostate Cancer Biomarker Companies Ranked by Revenue
3.3 Global Prostate Cancer Biomarker Revenue by Companies
3.4 Top 3 and Top 5 Prostate Cancer Biomarker Companies in Global Market, by Revenue in 2021
3.5 Global Companies Prostate Cancer Biomarker Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prostate Cancer Biomarker Players in Global Market
3.6.1 List of Global Tier 1 Prostate Cancer Biomarker Companies
3.6.2 List of Global Tier 2 and Tier 3 Prostate Cancer Biomarker Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Prostate Cancer Biomarker Market Size Markets, 2021 & 2028
4.1.2 Urine
4.1.3 Blood
4.1.4 Serum
4.2 By Type - Global Prostate Cancer Biomarker Revenue & Forecasts
4.2.1 By Type - Global Prostate Cancer Biomarker Revenue, 2017-2022
4.2.2 By Type - Global Prostate Cancer Biomarker Revenue, 2023-2028
4.2.3 By Type - Global Prostate Cancer Biomarker Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Prostate Cancer Biomarker Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Cancer Institutes
5.2 By Application - Global Prostate Cancer Biomarker Revenue & Forecasts
5.2.1 By Application - Global Prostate Cancer Biomarker Revenue, 2017-2022
5.2.2 By Application - Global Prostate Cancer Biomarker Revenue, 2023-2028
5.2.3 By Application - Global Prostate Cancer Biomarker Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Prostate Cancer Biomarker Market Size, 2021 & 2028
6.2 By Region - Global Prostate Cancer Biomarker Revenue & Forecasts
6.2.1 By Region - Global Prostate Cancer Biomarker Revenue, 2017-2022
6.2.2 By Region - Global Prostate Cancer Biomarker Revenue, 2023-2028
6.2.3 By Region - Global Prostate Cancer Biomarker Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Prostate Cancer Biomarker Revenue, 2017-2028
6.3.2 US Prostate Cancer Biomarker Market Size, 2017-2028
6.3.3 Canada Prostate Cancer Biomarker Market Size, 2017-2028
6.3.4 Mexico Prostate Cancer Biomarker Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Prostate Cancer Biomarker Revenue, 2017-2028
6.4.2 Germany Prostate Cancer Biomarker Market Size, 2017-2028
6.4.3 France Prostate Cancer Biomarker Market Size, 2017-2028
6.4.4 U.K. Prostate Cancer Biomarker Market Size, 2017-2028
6.4.5 Italy Prostate Cancer Biomarker Market Size, 2017-2028
6.4.6 Russia Prostate Cancer Biomarker Market Size, 2017-2028
6.4.7 Nordic Countries Prostate Cancer Biomarker Market Size, 2017-2028
6.4.8 Benelux Prostate Cancer Biomarker Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Prostate Cancer Biomarker Revenue, 2017-2028
6.5.2 China Prostate Cancer Biomarker Market Size, 2017-2028
6.5.3 Japan Prostate Cancer Biomarker Market Size, 2017-2028
6.5.4 South Korea Prostate Cancer Biomarker Market Size, 2017-2028
6.5.5 Southeast Asia Prostate Cancer Biomarker Market Size, 2017-2028
6.5.6 India Prostate Cancer Biomarker Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Prostate Cancer Biomarker Revenue, 2017-2028
6.6.2 Brazil Prostate Cancer Biomarker Market Size, 2017-2028
6.6.3 Argentina Prostate Cancer Biomarker Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Prostate Cancer Biomarker Revenue, 2017-2028
6.7.2 Turkey Prostate Cancer Biomarker Market Size, 2017-2028
6.7.3 Israel Prostate Cancer Biomarker Market Size, 2017-2028
6.7.4 Saudi Arabia Prostate Cancer Biomarker Market Size, 2017-2028
6.7.5 UAE Prostate Cancer Biomarker Market Size, 2017-2028
7 Players Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Corporate Summary
7.1.2 Thermo Fisher Scientific Business Overview
7.1.3 Thermo Fisher Scientific Prostate Cancer Biomarker Major Product Offerings
7.1.4 Thermo Fisher Scientific Prostate Cancer Biomarker Revenue in Global Market (2017-2022)
7.1.5 Thermo Fisher Scientific Key News
7.2 QIAGEN
7.2.1 QIAGEN Corporate Summary
7.2.2 QIAGEN Business Overview
7.2.3 QIAGEN Prostate Cancer Biomarker Major Product Offerings
7.2.4 QIAGEN Prostate Cancer Biomarker Revenue in Global Market (2017-2022)
7.2.5 QIAGEN Key News
7.3 Roche Diagnostics
7.3.1 Roche Diagnostics Corporate Summary
7.3.2 Roche Diagnostics Business Overview
7.3.3 Roche Diagnostics Prostate Cancer Biomarker Major Product Offerings
7.3.4 Roche Diagnostics Prostate Cancer Biomarker Revenue in Global Market (2017-2022)
7.3.5 Roche Diagnostics Key News
7.4 Beckman Coulter
7.4.1 Beckman Coulter Corporate Summary
7.4.2 Beckman Coulter Business Overview
7.4.3 Beckman Coulter Prostate Cancer Biomarker Major Product Offerings
7.4.4 Beckman Coulter Prostate Cancer Biomarker Revenue in Global Market (2017-2022)
7.4.5 Beckman Coulter Key News
7.5 Myriad Genetics
7.5.1 Myriad Genetics Corporate Summary
7.5.2 Myriad Genetics Business Overview
7.5.3 Myriad Genetics Prostate Cancer Biomarker Major Product Offerings
7.5.4 Myriad Genetics Prostate Cancer Biomarker Revenue in Global Market (2017-2022)
7.5.5 Myriad Genetics Key News
7.6 Sanofi-Aventis
7.6.1 Sanofi-Aventis Corporate Summary
7.6.2 Sanofi-Aventis Business Overview
7.6.3 Sanofi-Aventis Prostate Cancer Biomarker Major Product Offerings
7.6.4 Sanofi-Aventis Prostate Cancer Biomarker Revenue in Global Market (2017-2022)
7.6.5 Sanofi-Aventis Key News
7.7 Pfizer
7.7.1 Pfizer Corporate Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Prostate Cancer Biomarker Major Product Offerings
7.7.4 Pfizer Prostate Cancer Biomarker Revenue in Global Market (2017-2022)
7.7.5 Pfizer Key News
7.8 MDx Health
7.8.1 MDx Health Corporate Summary
7.8.2 MDx Health Business Overview
7.8.3 MDx Health Prostate Cancer Biomarker Major Product Offerings
7.8.4 MDx Health Prostate Cancer Biomarker Revenue in Global Market (2017-2022)
7.8.5 MDx Health Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Prostate Cancer Biomarker Market Opportunities & Trends in Global Market
Table 2. Prostate Cancer Biomarker Market Drivers in Global Market
Table 3. Prostate Cancer Biomarker Market Restraints in Global Market
Table 4. Key Players of Prostate Cancer Biomarker in Global Market
Table 5. Top Prostate Cancer Biomarker Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Prostate Cancer Biomarker Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Prostate Cancer Biomarker Revenue Share by Companies, 2017-2022
Table 8. Global Companies Prostate Cancer Biomarker Product Type
Table 9. List of Global Tier 1 Prostate Cancer Biomarker Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prostate Cancer Biomarker Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Prostate Cancer Biomarker Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Prostate Cancer Biomarker Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Prostate Cancer Biomarker Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Prostate Cancer Biomarker Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Prostate Cancer Biomarker Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Prostate Cancer Biomarker Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Prostate Cancer Biomarker Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Prostate Cancer Biomarker Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Prostate Cancer Biomarker Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Prostate Cancer Biomarker Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Prostate Cancer Biomarker Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Prostate Cancer Biomarker Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Prostate Cancer Biomarker Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Prostate Cancer Biomarker Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Prostate Cancer Biomarker Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Prostate Cancer Biomarker Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Prostate Cancer Biomarker Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Prostate Cancer Biomarker Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Prostate Cancer Biomarker Revenue, (US$, Mn), 2023-2028
Table 30. Thermo Fisher Scientific Corporate Summary
Table 31. Thermo Fisher Scientific Prostate Cancer Biomarker Product Offerings
Table 32. Thermo Fisher Scientific Prostate Cancer Biomarker Revenue (US$, Mn), (2017-2022)
Table 33. QIAGEN Corporate Summary
Table 34. QIAGEN Prostate Cancer Biomarker Product Offerings
Table 35. QIAGEN Prostate Cancer Biomarker Revenue (US$, Mn), (2017-2022)
Table 36. Roche Diagnostics Corporate Summary
Table 37. Roche Diagnostics Prostate Cancer Biomarker Product Offerings
Table 38. Roche Diagnostics Prostate Cancer Biomarker Revenue (US$, Mn), (2017-2022)
Table 39. Beckman Coulter Corporate Summary
Table 40. Beckman Coulter Prostate Cancer Biomarker Product Offerings
Table 41. Beckman Coulter Prostate Cancer Biomarker Revenue (US$, Mn), (2017-2022)
Table 42. Myriad Genetics Corporate Summary
Table 43. Myriad Genetics Prostate Cancer Biomarker Product Offerings
Table 44. Myriad Genetics Prostate Cancer Biomarker Revenue (US$, Mn), (2017-2022)
Table 45. Sanofi-Aventis Corporate Summary
Table 46. Sanofi-Aventis Prostate Cancer Biomarker Product Offerings
Table 47. Sanofi-Aventis Prostate Cancer Biomarker Revenue (US$, Mn), (2017-2022)
Table 48. Pfizer Corporate Summary
Table 49. Pfizer Prostate Cancer Biomarker Product Offerings
Table 50. Pfizer Prostate Cancer Biomarker Revenue (US$, Mn), (2017-2022)
Table 51. MDx Health Corporate Summary
Table 52. MDx Health Prostate Cancer Biomarker Product Offerings
Table 53. MDx Health Prostate Cancer Biomarker Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Prostate Cancer Biomarker Segment by Type in 2021
Figure 2. Prostate Cancer Biomarker Segment by Application in 2021
Figure 3. Global Prostate Cancer Biomarker Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Prostate Cancer Biomarker Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Prostate Cancer Biomarker Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Prostate Cancer Biomarker Revenue in 2021
Figure 8. By Type - Global Prostate Cancer Biomarker Revenue Market Share, 2017-2028
Figure 9. By Application - Global Prostate Cancer Biomarker Revenue Market Share, 2017-2028
Figure 10. By Region - Global Prostate Cancer Biomarker Revenue Market Share, 2017-2028
Figure 11. By Country - North America Prostate Cancer Biomarker Revenue Market Share, 2017-2028
Figure 12. US Prostate Cancer Biomarker Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Prostate Cancer Biomarker Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Prostate Cancer Biomarker Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Prostate Cancer Biomarker Revenue Market Share, 2017-2028
Figure 16. Germany Prostate Cancer Biomarker Revenue, (US$, Mn), 2017-2028
Figure 17. France Prostate Cancer Biomarker Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Prostate Cancer Biomarker Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Prostate Cancer Biomarker Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Prostate Cancer Biomarker Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Prostate Cancer Biomarker Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Prostate Cancer Biomarker Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Prostate Cancer Biomarker Revenue Market Share, 2017-2028
Figure 24. China Prostate Cancer Biomarker Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Prostate Cancer Biomarker Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Prostate Cancer Biomarker Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Prostate Cancer Biomarker Revenue, (US$, Mn), 2017-2028
Figure 28. India Prostate Cancer Biomarker Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Prostate Cancer Biomarker Revenue Market Share, 2017-2028
Figure 30. Brazil Prostate Cancer Biomarker Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Prostate Cancer Biomarker Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Prostate Cancer Biomarker Revenue Market Share, 2017-2028
Figure 33. Turkey Prostate Cancer Biomarker Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Prostate Cancer Biomarker Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Prostate Cancer Biomarker Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Prostate Cancer Biomarker Revenue, (US$, Mn), 2017-2028
Figure 37. Thermo Fisher Scientific Prostate Cancer Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. QIAGEN Prostate Cancer Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Roche Diagnostics Prostate Cancer Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Beckman Coulter Prostate Cancer Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Myriad Genetics Prostate Cancer Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Sanofi-Aventis Prostate Cancer Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Pfizer Prostate Cancer Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. MDx Health Prostate Cancer Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
